Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Peter R Rossing, Cheuk‐Chun Szeto, Diego Echeverri, Edouard Martin et autres
us, de, br, ca, nl, au, jp, mx, dk (code pays fourni par la source)